Cargando…
Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
COSYCONET 1 is the only German COPD cohort which is large enough to be internationally comparable. The recruitment, which started in 2010 and ended in December 2013, comprised 2741 patients with the diagnosis of COPD who were subsequently investigated in regular follow-up visits. All visits included...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931494/ https://www.ncbi.nlm.nih.gov/pubmed/36526266 http://dx.doi.org/10.1055/a-1966-0848 |
_version_ | 1784889262343192576 |
---|---|
author | Kahnert, Kathrin Fischer, Carolina Alter, Peter Trudzinski, Franziska Welte, Tobias Behr, Jürgen Herth, Felix Kauczor, Hans-Ulrich Bals, Robert Watz, Henrik Rabe, Klaus Söhler, Sandra Kokot, Inge Vogelmeier, Claus Jörres, Rudolf |
author_facet | Kahnert, Kathrin Fischer, Carolina Alter, Peter Trudzinski, Franziska Welte, Tobias Behr, Jürgen Herth, Felix Kauczor, Hans-Ulrich Bals, Robert Watz, Henrik Rabe, Klaus Söhler, Sandra Kokot, Inge Vogelmeier, Claus Jörres, Rudolf |
author_sort | Kahnert, Kathrin |
collection | PubMed |
description | COSYCONET 1 is the only German COPD cohort which is large enough to be internationally comparable. The recruitment, which started in 2010 and ended in December 2013, comprised 2741 patients with the diagnosis of COPD who were subsequently investigated in regular follow-up visits. All visits included a comprehensive functional and clinical characterisation. On the basis of this detailed data set, it was possible to address a large number of clinical questions. These questions ranged from the prescription of medication, the detailed analysis of comorbidities, in particular cardiovascular disease, and biomarker assessment to radiological and health-economic aspects. Currently, more than 60 publications of COSYCONET data are internationally available. The present overview provides a description of all the results that were obtained, focussing on the relationship between different clinical and functional aspects as well as their potential practical consequences. In addition, information on the follow-up study COSYCONET 2 is given. |
format | Online Article Text |
id | pubmed-9931494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-99314942023-02-16 Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? Kahnert, Kathrin Fischer, Carolina Alter, Peter Trudzinski, Franziska Welte, Tobias Behr, Jürgen Herth, Felix Kauczor, Hans-Ulrich Bals, Robert Watz, Henrik Rabe, Klaus Söhler, Sandra Kokot, Inge Vogelmeier, Claus Jörres, Rudolf Pneumologie COSYCONET 1 is the only German COPD cohort which is large enough to be internationally comparable. The recruitment, which started in 2010 and ended in December 2013, comprised 2741 patients with the diagnosis of COPD who were subsequently investigated in regular follow-up visits. All visits included a comprehensive functional and clinical characterisation. On the basis of this detailed data set, it was possible to address a large number of clinical questions. These questions ranged from the prescription of medication, the detailed analysis of comorbidities, in particular cardiovascular disease, and biomarker assessment to radiological and health-economic aspects. Currently, more than 60 publications of COSYCONET data are internationally available. The present overview provides a description of all the results that were obtained, focussing on the relationship between different clinical and functional aspects as well as their potential practical consequences. In addition, information on the follow-up study COSYCONET 2 is given. Georg Thieme Verlag KG 2022-12-16 /pmc/articles/PMC9931494/ /pubmed/36526266 http://dx.doi.org/10.1055/a-1966-0848 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Kahnert, Kathrin Fischer, Carolina Alter, Peter Trudzinski, Franziska Welte, Tobias Behr, Jürgen Herth, Felix Kauczor, Hans-Ulrich Bals, Robert Watz, Henrik Rabe, Klaus Söhler, Sandra Kokot, Inge Vogelmeier, Claus Jörres, Rudolf Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? |
title | Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? |
title_full | Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? |
title_fullStr | Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? |
title_full_unstemmed | Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? |
title_short | Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter? |
title_sort | was haben wir aus der deutschen copd-kohorte cosyconet gelernt und wie geht es weiter? |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931494/ https://www.ncbi.nlm.nih.gov/pubmed/36526266 http://dx.doi.org/10.1055/a-1966-0848 |
work_keys_str_mv | AT kahnertkathrin washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT fischercarolina washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT alterpeter washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT trudzinskifranziska washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT weltetobias washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT behrjurgen washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT herthfelix washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT kauczorhansulrich washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT balsrobert washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT watzhenrik washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT rabeklaus washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT sohlersandra washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT kokotinge washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT vogelmeierclaus washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter AT jorresrudolf washabenwirausderdeutschencopdkohortecosyconetgelerntundwiegehtesweiter |